Summary
- Current Price
- As of today, CRNX price is $84.85, up +0.01% on
- Current Price All-Time High
- CRNX price is currently -0.04% below its historical high of $84.89 set on
- Market Cap
- CRNX current market cap is $9B, up +212.04% over the past 365 days
- Revenue
- CRNX current annual revenue is $7.70M, up +640.71% year-over-year
- Next Earnings
- The next earnings release for CRNX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Crinetics Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CRNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | crinetics.com |
| Employees | 437 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $84.85 | |
| Price, 1D Change | +0.01% | |
| $9B | ||
| - | ||
| - | ||
| 0.45 | ||
| $7.70M | ||
| Revenue, 1Y Change | +640.71% | |
| -$4.95 | ||
| EPS, 1Y Change | -33.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.95 | ||
| EPS Estimate | -$4.13 | N/A |
| EPS Est. Change | +16.59% | N/A |
| $7.70M | ||
| Revenue Estimate | $76.86M | N/A |
| Revenue Est. Change | +898.71% | N/A |
| Current Price | $84.85 | |
| Price Target | $85.00 | - |
| Price Tgt. Change | +0.18% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.71 | -$3.69 | +0.33% | |
| -$5.02 | -$4.95 | +1.53% | |
| -$4.13 | N/A | +16.59% | |
| -$4.05 | N/A | +18.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.60M | $1.04M | -35.25% | |
| $6.33M | $7.70M | +21.61% | |
| $76.86M | N/A | +898.71% | |
| $180.43M | N/A | +2,244.48% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $84.85 | |
| $50.01 | ||
| $72.87 | ||
| $53.57 | ||
| $73.96 | ||
| $2.70 | ||
| 0.45 | ||
| $0.46 | ||
| 89.70 | ||
| 1.68% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $7.70M | ||
| -$4.95 | ||
| $0.00 | ||
| 35.47% | ||
| -$516.77M | ||
| -6,714.77% | ||
| -$465.32M | ||
| -6,046.22% | ||
| -$512.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 12.32 | ||
| 12.30 | ||
| - | ||
| 4 | ||
| 36.94 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 213.54 | ||
| 7.55 | ||
| -14.40 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $992.08M | ||
| $1.03B | ||
| $1.14B | ||
| $1.05B | ||
| $143.41M | ||
| $85.07M | ||
| $48.54M | ||
| $6.49M | ||
| $22.61M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $473.01M | ||
| $519.50M | ||
| $4.97M | ||
| $191.33M | ||
| $3.89M | ||
| $0.00 | ||
| $180.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$377.92M | ||
| $173.91M | ||
| $40.61M | ||
| $5.76M | ||
| -$383.68M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| TD Cowen | → | |
| Evercore ISI Group | → | |
| Oppenheimer | → | |
| Jones Trading | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| Baird | → | |
| UBS |
Analyst sentiment
Institutional ownership
No data
Screeners with CRNX
FAQ
- What is the ticker symbol for Crinetics Pharmaceuticals, Inc.?
- The ticker symbol for Crinetics Pharmaceuticals, Inc. is NASDAQ:CRNX
- Does Crinetics Pharmaceuticals, Inc. pay dividends?
- No, Crinetics Pharmaceuticals, Inc. does not pay dividends
- What sector is Crinetics Pharmaceuticals, Inc. in?
- Crinetics Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Crinetics Pharmaceuticals, Inc. in?
- Crinetics Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Crinetics Pharmaceuticals, Inc. based in?
- Crinetics Pharmaceuticals, Inc. is headquartered in United States
- When did Crinetics Pharmaceuticals, Inc. go public?
- Crinetics Pharmaceuticals, Inc. initial public offering (IPO) was on July 18, 2018
- Is Crinetics Pharmaceuticals, Inc. in the S&P 500?
- No, Crinetics Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Crinetics Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Crinetics Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Crinetics Pharmaceuticals, Inc. in the Dow Jones?
- No, Crinetics Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Crinetics Pharmaceuticals, Inc. last earnings report?
- Crinetics Pharmaceuticals, Inc.'s most recent earnings report was on August 3, 2026
- When does Crinetics Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Crinetics Pharmaceuticals, Inc. is November 5, 2026
Data Sources & References
- CRNX Official Website www.crinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658247/000165824726000012/0001658247-26-000012-index.htm
- CRNX Profile on Yahoo Finance finance.yahoo.com/quote/CRNX
- CRNX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crnx